Longaeva

Longaeva is a biotechnology company focused on the discovery and development of therapeutics that target the fundamental biological drivers of aging. The company utilizes a proprietary artificial intelligence platform to identify novel compounds and repurposed drugs capable of modulating key longevity pathways, such as sirtuin activation and mTOR inhibition. By integrating multi-omic data with high-throughput screening, Longaeva aims to extend healthy human lifespan and delay the onset of age-related chronic diseases. Their current pipeline includes several early-stage programs targeting metabolic health and neuroprotection. Longaeva operates at the intersection of computational biology and regenerative medicine to translate longevity science into clinical interventions.